BLC — Bastide le Confort Medical SA Share Price
- €131.31m
- €517.30m
- €529.76m
- 74
- 77
- 53
- 81
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 6.36 | ||
PEG Ratio (f) | 0.14 | ||
EPS Growth (f) | 82.71% | ||
Dividend Yield (f) | 1.58% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.65 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 3.52 | ||
Price to Sales | 0.25 | ||
EV to EBITDA | 5.06 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 9.03% | ||
Return on Equity | 8.82% | ||
Operating Margin | 7.35% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 382.71 | 444.07 | 468.3 | 508.03 | 529.75 | 556 | 591 | 9.55% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +41.26 | +19.54 | +5.05 | +1.92 | -59.73 | +190.69 | +11.4 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Bastide le Confort Medical SA is a France-based company specializes in home health services for the elderly, ill, and handicapped. The Company activity is organized around three families of products and services such as home care equipment and services, respiratory assistance equipment and services, perfusion and nutrition equipment and services, It provides hospital beds, personal assistance products, etc. The Company provides mainly respirators, oxygen concentrators, and oxygen tanks; The offers perfusion, nutrition, and insulin pumps and syringe-drivers. It offers devices to support diabetic patients towards daily comfort and a normal life. The Company offers wide range of products and services to relieve patients losing their autonomy. It fer tailor-made, solutions for a secure, humane, and deeply respectful care pathway.
Directors
- Vincent Bastide CHM (52)
- Dorothee Bravard DRC (45)
- Olivier Bernard Jourdanney DRC (44)
- Claude Vincent DRC (63)
- Last Annual
- June 30th, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- January 1st, 1976
- Public Since
- May 15th, 1997
- No. of Employees
- 3,546
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 7,303,385
- Address
- Centre d'activite Euro 2000, CAISSARGUES, 30132
- Web
- https://www.bastideleconfortmedical.com/
- Phone
- +33 466386808
- Auditors
- KPMG
Upcoming Events for BLC
Half Year 2025 Bastide le Confort Medical SA Earnings Release
Similar to BLC
Clariane SE
Euronext - Paris
Emeis SA
Euronext - Paris
Eurofins Scientific SE
Euronext - Paris
Klea Holding
Euronext - Paris
LNA Sante SA
Euronext - Paris
FAQ
As of Today at 18:33 UTC, shares in Bastide le Confort Medical SA are trading at €17.98. This share price information is delayed by 15 minutes.
Shares in Bastide le Confort Medical SA last closed at €17.98 and the price had moved by -13.76% over the past 365 days. In terms of relative price strength the Bastide le Confort Medical SA share price has underperformed the FTSE Global All Cap Index by -25.15% over the past year.
The overall consensus recommendation for Bastide le Confort Medical SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreBastide le Confort Medical SA does not currently pay a dividend.
Bastide le Confort Medical SA does not currently pay a dividend.
Bastide le Confort Medical SA does not currently pay a dividend.
To buy shares in Bastide le Confort Medical SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €17.98, shares in Bastide le Confort Medical SA had a market capitalisation of €131.31m.
Here are the trading details for Bastide le Confort Medical SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: BLC
Based on an overall assessment of its quality, value and momentum Bastide le Confort Medical SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Bastide le Confort Medical SA is €27.80. That is 54.62% above the last closing price of €17.98.
Analysts covering Bastide le Confort Medical SA currently have a consensus Earnings Per Share (EPS) forecast of €2.72 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bastide le Confort Medical SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -3.27%.
As of the last closing price of €17.98, shares in Bastide le Confort Medical SA were trading -8.32% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bastide le Confort Medical SA PE ratio based on its reported earnings over the past 12 months is 6.36. The shares last closed at €17.98.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Bastide le Confort Medical SA's management team is headed by:
- Vincent Bastide - CHM
- Dorothee Bravard - DRC
- Olivier Bernard Jourdanney - DRC
- Claude Vincent - DRC